TRADING UPDATES: Zenith Energy in Rome buy; Concurrent revenue rises
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.475p on 13-07-2026 at 16:30:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.50p |
| Sell | 0.45p |
| Last Trade: | Buy 2,000.00 at 0.50p |
| Day's Volume: | 3,014,545 |
| Last Close: | 0.475p |
| Open: | 0.475p |
| ISIN: | GB00BNRRP542 |
| Day's Range | 0.475p - 0.475p |
| 52wk Range: | 0.335p - 1.30p |
| Market Capitalisation: | £16.41m |
| VWAP: | 0.483417p |
| Shares in Issue: | 3.46b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Aptamer Group (APTA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2,000 | 0.50p | Ordinary |
15:28:57 - 13-Jul-26 |
| Sell* | 2,172 | 0.45p | Ordinary |
13:48:41 - 13-Jul-26 |
| Sell* | 3,000 | 0.4715p | Ordinary |
13:15:14 - 13-Jul-26 |
| Buy* | 190,000 | 0.4895p | Ordinary |
09:39:47 - 13-Jul-26 |
| Buy* | 109,911 | 0.4895p | Ordinary |
09:27:03 - 13-Jul-26 |
| Buy* | 498,902 | 0.49p | Ordinary |
09:16:57 - 13-Jul-26 |
| Buy* | 999,800 | 0.4845p | Ordinary |
09:06:11 - 13-Jul-26 |
| Buy* | 100,000 | 0.4845p | Ordinary |
09:01:28 - 13-Jul-26 |
| Buy* | 411,973 | 0.4845p | Ordinary |
08:31:49 - 13-Jul-26 |
| Sell* | 175,000 | 0.4615p | Ordinary |
08:14:50 - 13-Jul-26 |
Aptamer Group (APTA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Jul 2026 7:00 am | RNS | Aptamer initiates Ebola diagnostic test programme |
| 25th Jun 2026 7:00 am | RNS | Programme and technical development update |
| 8th Jun 2026 7:00 am | RNS | Rapid testing programme for fortified foods |
| 13th Apr 2026 1:08 pm | RNS | Result of General Meeting |
| 31st Mar 2026 7:00 am | RNS | Result of Retail Offer and Posting of Notice of GM |
| 26th Mar 2026 7:05 am | RNS | Retail Offer to raise up to £0.5 million |
| 26th Mar 2026 7:00 am | RNS | Results of Placing |
| 25th Mar 2026 7:10 am | RNS | Interim Results and Notice of Investor Webinar |
| 25th Mar 2026 7:00 am | RNS | Proposed Placing, Subscription and Retail Offer |
| 18th Mar 2026 7:00 am | RNS | Launch of targeted radiopharmaceutical programme |